What stage does BIOSPRING PARTNERS invest at?

BIOSPRING PARTNERS invests at the Growth, Late Stage stages.

What sectors does BIOSPRING PARTNERS focus on?

BIOSPRING PARTNERS focuses on Biotech, Digital Health, Healthtech, Medical Devices, SaaS.

Where is BIOSPRING PARTNERS located?

BIOSPRING PARTNERS is headquartered in New York, US.

BIOSPRING PARTNERS

Growth equityActively deploying

New York · Growth–Late Stage · 22 people tracked

Also known as BIOSPRING MANAGEMENT, LLC · Biospring Partners ABZ · Biospring Partners CHR · Biospring Partners Tech

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

Biospring Partners partners with technology-enabled, EBITDA-positive pharma services companies driving innovation across manufacturing and clinical trial services. Its portfolio companies manufacture and support the supply chain for complex medicines, including biologics, bioconjugates, cell therapies, and peptides, providing science, scale, and quality to the life sciences industry and patients. The firm also backs businesses modernizing the clinical trials workflow through improved site operations, smarter patient recruitment, expanded participant access, and purpose-built technology. Focus areas include outsourced biologics and cell therapy manufacturing, clinical trial site networks, digitized pathology, lab procurement marketplaces, and direct-to-patient platforms for pharma.

Invests inBiotech Digital Health Healthtech Medical Devices SaaSBostonNew YorkUnited KingdomUnited States

Source: firm website, verified Aug 3, 2026.

Stage

Growth–Late Stage

New York, New York, US

Instruments

Equity

Founded

2020

AUM

$245M

VC funds

Tracked investments

Team · 22 people

from the firm's website & public directories

Jennifer Lum· Managing Partner· United Statesin 𝕏

Jennifer Lum is a Managing Partner at Biospring Partners with a background as an investor and entrepreneur. She co-founded Forge.AI (acquired by FiscalNote) and Adelphic (acquired by Time), and was an early team member at Quattro Wireless (acquired by Apple), m-Qube (acquired by VeriSign), and WebHosting.com (acquired by AT&T). She also serves in advisory roles at Harvard Business School, MIT's Martin Trust Center for Entrepreneurship, and Harvard Law School's Petrie-Flom Center.

j•••@biospring.comreveal

Michelle Detwiler· Managing Partner, MD, PhD· New York, New York, United Statesin

Michelle Detwiler is a Co-Founder and Managing Partner at Biospring Partners, a healthcare growth equity firm focused on pharma services including outsourced complex manufacturing and clinical trial services. Previously, she was a Managing Director at General Atlantic, where she established their first life sciences investment platform, and Co-Founder and General Partner of Longwood Fund, a Boston-based healthcare investment firm. She holds a Bachelor of Medicine and Bachelor of Surgery from the University of Oxford Medical School and a Doctor of Philosophy in Human Physiology from the University of Oxford, and serves on the boards of Xavier University of Louisiana, Beth Israel Deaconess Medical Center, and the Women's Foundation of Boston.

Michelle Dipp· Managing Partner

m•••@biospring.comreveal

Socrates Zacharias· Principal· United Statesin

Socrates Zacharias is a Principal at Biospring Partners, where he focuses on investments in biomanufacturing, radiopharma manufacturing, and pharma services. He previously invested in healthcare and life sciences with UPMC Enterprises, worked in the capital markets group at PNC, and started his career in healthcare investment banking at Leerink Partners. He earned a B.S. in Biological Sciences and Psychology and an M.S. in Biotechnology and Management, both from Carnegie Mellon University.

s•••@biospring.comreveal

Ben Morss· Operations Associate· New York City Metropolitan Areain

Billy Breed· Director of Business Development· New York, New York, United Statesin

Billy Breed is Director of Business Development at Biospring Partners LLC, a life sciences growth-equity firm investing in technology-enabled, EBITDA-positive pharma services and clinical trial infrastructure. His responsibilities span capital formation and institutional fundraising, investment sourcing and evaluation across biomanufacturing and clinical services, and strategic initiatives supporting firm leadership. Previously, he served as Chief of Staff to the CEO at Aqueduct Capital Group and worked as an entrepreneur and film financing professional, and holds an MBA from USC Marshall and an undergraduate degree from the University of Richmond.

Bob Pozen· Advisor· Boston, Massachusetts, United Statesin

Former Chair of MFS and former President of Fidelity Investments.

Brian Malone· Executive Vice President, Finance

Chad Hooper· Operating Partner· Greater Wilmington Areain

Chad Hooper is an Operating Partner at Biospring Partners. He has experience in corporate development and finance, with a background in developing growth strategies and executing internal builds and mergers and acquisitions.

David Mauney· Senior Advisor· Charlotte, North Carolina, United Statesin

Former Managing Director at Koch Disruptive Technologies.

Drew Pearson· Head of Portfolio Management· New Canaan, Connecticut, United Statesin

Jeff Bullock· Chief Financial Officer· San Francisco, California, United Statesin

John Baldoni· Advisor

Former EVP of R&D at GSK.

John Bell· Senior Advisor

Former Regius Chair of Medicine at the University of Oxford.

John Sexton· Advisor

President Emeritus of New York University.

Jordan Feyko· Vice President· Los Angeles, California, United Statesin

Jordan Feyko is a Vice President at Biospring Partners, where he leads the firm's investing in outsourced clinical trial services. He previously held roles on the investment team at Health Velocity Capital, at Francisco Partners working on healthcare and technology transactions, and at Goldman Sachs in its AIMS private equity group, and worked as a consultant at Bain & Company. He holds a B.A. in Applied Mathematics and Economics from Harvard University and an M.B.A. from the Stanford Graduate School of Business.

j•••@biospring.comreveal

Matt McBryan· Associate· New York, New York, United Statesin

Matt McBryan is an Associate at Biospring. He previously worked as an investment banking analyst in the Healthcare Group at Perella Weinberg Partners. He holds a B.B.A. in Finance from Villanova University.

m•••@biospring.comreveal

Moncef Slaoui· Senior Advisor· United Statesin

Former Chairman of Pharma R&D and Chairman of Global R&D for Vaccines & Oncology at GSK; involved in Operation Warp Speed.

Peter Henry· Advisor

Senior Fellow at the Hoover Institution.

Precious Brown· Office Manager

Qi Wang· Advisor

CIO of Portfolio Implementation at PIMCO.

Sid Nambiar· Analyst

s•••@biospring.comreveal

What they invest in

from 5 of 8 portfolio companies

Biotech ×5Healthtech ×2AI & Machine Learning ×1Enterprise Software ×1Medical Devices ×1SaaS ×1

HQs:United States×2

Investments · 8 tracked

founders shown can be your intro path

Labvivalabviva.comin✓ verified

Labviva is an AI-native procurement platform that unifies the life sciences supply chain, helping research organizations optimize procurement processes and reduce costs.

AI & Machine LearningBiotechEnterprise SoftwareSaaS

SiamakinRenikainJenniferinCarlo(GM of Europe)inNick Premnath(SVP of Commercial Strategy)inSarah Fay(Director)

Abzenaabzena.comin 𝕏

BiotechCambridge

Nigel Pitchford(Director)Leigh Pierce(Executive Officer)William John Edward Burt(Executive Officer, Director)Kenneth Cunningham(Director)Julian Smith(Executive Officer, Director)Anthony Brampton(Director)

Cedarhealthresearchcedarhealthresearch.comin 𝕏

Cedar Health Research conducts clinical research studies across Texas communities, partnering with healthcare providers to offer participants access to new treatment options.

BiotechHealthtechDallas, US

Cenexelresearchcenexelresearch.com

CenExel operates a clinical research network that conducts trials and studies for pharmaceutical and biotechnology companies developing new therapies.

BiotechHealthtech

Ixlayerixlayer.comin 𝕏

Kinicitikiniciti.com

Kiniciti is a holding company and investment platform that partners with and invests in cell and gene therapy companies, including operating companies Cellistic and Ncardia.

BiotechMedical Devices

Partner Loginfundpanel.io

Pathaipathai.com

AI-powered pathology for improved patient outcomes

Boston, US

ANDREW BECK(Executive Officer, Director)ADITYA KHOSLA(Executive Officer, Director)STANLEY LAPIDUS(Director)JEFF LEIDEN(Director)MICHELLE DIPP(Director)

Fund performance · per public LP disclosures · 2

as of Dec 2024

Fund	Vintage	Committed	Net IRR	TVPI	DPI
Biospring Partners Fund IILPs: Texas Municipal Retirement System, Los Angeles City Employees' Retirement System	2024	—	—	0.00x	—
Biospring Partners FundLPs: Los Angeles City Employees' Retirement System	2020	—	7.8%	13.62x	6.82x

Source: public limited-partner disclosures (CalPERS, CalSTRS). Net IRR / TVPI / DPI as reported by the limited partner; a fund's early-year IRR is an interim estimate (J-curve).

Frequently asked questions

What stage does BIOSPRING PARTNERS invest at?: BIOSPRING PARTNERS invests at the Growth, Late Stage stages.
What sectors does BIOSPRING PARTNERS focus on?: BIOSPRING PARTNERS focuses on Biotech, Digital Health, Healthtech, Medical Devices, SaaS.
Where is BIOSPRING PARTNERS located?: BIOSPRING PARTNERS is headquartered in New York, US.

Images

Co-investors · 55

General Catalyst

General Catalyst is a venture capital and investment firm that backs founders across industries, with a strong focus on AI-driven transformation, fintech, healthcare, and other sectors.

Both backed · 1

Pathai

$30M

B Capital Group

B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.

Both backed · 1

Labviva

$10M – $50M

Village Global

Village Global is a venture capital firm backed by a network of 400+ founders, operator angels, and prominent LPs from leading tech companies, offering founders access to its network alongside capital.

Both backed · 1

Labviva

$100K – $500K

Glasswing Ventures

Glasswing Ventures is an early-stage venture capital firm that supports startups through its Building Partners model, providing operational expertise across go-to-market, product, engineering, and finance.

Both backed · 1

Labviva

$100K – $5M

Bessemer Venture Partners

Bessemer Venture Partners is a venture capital firm that partners with entrepreneurs from early stages through every stage of growth, publishing investment roadmaps across multiple technology sectors.

$5M – $100M

Techstars

Techstars is a startup accelerator and early-stage investor that funds ambitious founders and provides capital, mentorship, and access to a global network of investors, operators, and corporate partners.

$220K

Founder Collective

Founder Collective is an early-stage venture capital firm focused on seed and pre-seed investments across all sectors.

Benchmark

Benchmark is a venture capital firm with offices in San Francisco and Woodside that invests in early-stage startups.

$100K – $30M

Unknown Ventures

Unknown is an investment firm focused on emerging market opportunities in live entertainment, biosciences, technology startups, and real estate, with a portfolio spanning music festivals, artist platforms, creator financial services, and event infrastructure.

Menlo Ventures

Menlo Ventures is a venture capital firm that backs transformative, early-stage technology companies reshaping how people live and work.

$1M – $20M

BoxGroup

BoxGroup is an early-stage venture capital firm that invests in startups at their earliest stages.

$1M

Plug and Play Ventures

Plug and Play is an innovation platform that connects corporations, governments, startups, investors, and universities to drive innovation.

$50K – $12M

▶43 more co-investors

Goat Capital NextView Ventures C2 Investments Obvious Ventures Flybridge Capital Partners Cota Capital Resolute Ventures Stride VC Next47 Polaris Partners 01 Advisors Atlas Venture Pear VC Upfront Ventures BAM Ventures Accomplice WGI Group Unusual Ventures NextGen Venture Partners 23andMe Moxxie Ventures Baseline Ventures Tribeca Venture Partners Transmedia Capital Founders' Co-op Capital Factory Accelerator Ventures VitalStage Ventures Propeller VC BDC Venture Capital Predictive VC Xfund G20 Ventures XSeed Capital Cambrian Asset Management Kohala Ventures Boston Seed Capital C2 Ventures Data Point Capital Kain Capital 186 Ventures Impellent Ventures MBX Capital

Firms observed investing alongside BIOSPRING PARTNERS, from public investor directories. Shared companies are the overlap with BIOSPRING PARTNERS's recorded portfolio.

Similar investors

B Capital Group

$10M – $50M

DCVC (Data Collective)

DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.

$5M – $25M

GV (Google Ventures)

GV (formerly Google Ventures) is a venture investment firm that backs founders across many industries, aiming to build long-term relationships and support companies across multiple stages and milestones.

$250K – $50M

Khosla Ventures

Khosla Ventures is a venture capital firm known for backing bold, contrarian bets in world-class teams that can reshape entire industries.

$5K – $50M

Kleiner Perkins

Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, with a portfolio of companies from early stage through growth.

$500K – $15M